JENBURPHPharmaceuticals
Jenburkt Pharmaceuticals Ltd — Balance Sheet
₹955.45
+0.34%
Jenburkt Pharmaceuticals Ltd Balance Sheet (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Ordinary Shares Number | 0.44 Cr | 0.44 Cr | 0.44 Cr | 0.46 Cr | — |
| Share Issued | 0.44 Cr | 0.44 Cr | 0.46 Cr | 0.46 Cr | — |
| Total Debt | 3.89 Cr | 0.00 | 2.93 Cr | 6.75 Cr | — |
| Tangible Book Value | 171.55 Cr | 144.55 Cr | 122.20 Cr | 117.08 Cr | — |
| Invested Capital | 173.76 Cr | 144.94 Cr | 124.83 Cr | 123.20 Cr | — |
| Working Capital | 37.71 Cr | 93.35 Cr | 65.33 Cr | 54.62 Cr | — |
| Net Tangible Assets | 171.55 Cr | 144.55 Cr | 122.20 Cr | 117.08 Cr | — |
| Capital Lease Obligations | 1.92 Cr | 0.00 | 0.49 Cr | 0.94 Cr | — |
| Common Stock Equity | 171.78 Cr | 144.94 Cr | 122.39 Cr | 117.38 Cr | — |
| Total Capitalization | 171.78 Cr | 144.94 Cr | 122.39 Cr | 117.38 Cr | — |
| Total Equity Gross Minority Interest | 171.78 Cr | 144.94 Cr | 122.39 Cr | 117.38 Cr | — |
| Stockholders Equity | 171.78 Cr | 144.94 Cr | 122.39 Cr | 117.38 Cr | — |
| Capital Stock | 4.41 Cr | 4.41 Cr | 4.41 Cr | 4.59 Cr | — |
| Common Stock | 4.41 Cr | 4.41 Cr | 4.41 Cr | 4.59 Cr | — |
| Total Liabilities Net Minority Interest | 24.41 Cr | 20.16 Cr | 19.42 Cr | 25.57 Cr | — |
| Total Non Current Liabilities Net Minority Interest | 5.59 Cr | 3.78 Cr | 3.66 Cr | 4.29 Cr | — |
| Non Current Deferred Taxes Liabilities | 1.09 Cr | 0.79 Cr | 0.72 Cr | 0.86 Cr | — |
| Long Term Debt And Capital Lease Obligation | 1.49 Cr | — | 0.00 | 0.49 Cr | 0.94 Cr |
| Long Term Capital Lease Obligation | 1.49 Cr | — | 0.00 | 0.49 Cr | 0.94 Cr |
| Current Liabilities | 18.82 Cr | 16.38 Cr | 15.76 Cr | 21.28 Cr | — |
| Other Current Liabilities | 1.69 Cr | 1.63 Cr | 1.15 Cr | 1.15 Cr | — |
| Current Debt And Capital Lease Obligation | 2.40 Cr | 0.00 | 2.93 Cr | 6.27 Cr | — |
| Current Capital Lease Obligation | 0.42 Cr | 0.00 | 0.49 Cr | 0.45 Cr | — |
| Current Debt | 1.98 Cr | 0.00 | 2.44 Cr | 5.82 Cr | — |
| Current Provisions | 1.60 Cr | 0.93 Cr | 0.26 Cr | 0.26 Cr | — |
| Payables | 8.44 Cr | 13.19 Cr | 11.37 Cr | 12.74 Cr | — |
| Total Tax Payable | 0.29 Cr | 1.64 Cr | 0.34 Cr | 0.08 Cr | — |
| Accounts Payable | 8.16 Cr | 6.26 Cr | 6.10 Cr | 7.11 Cr | — |
| Total Assets | 196.19 Cr | 165.10 Cr | 141.81 Cr | 142.95 Cr | — |
| Total Non Current Assets | 139.65 Cr | 55.71 Cr | 60.76 Cr | 67.05 Cr | — |
| Other Non Current Assets | 2.77 Cr | 25.46 Cr | 12.02 Cr | 11.31 Cr | — |
| Non Current Deferred Taxes Assets | 1.47 Cr | 0.80 Cr | 0.42 Cr | 0.37 Cr | — |
| Investmentin Financial Assets | 80.47 Cr | 17.73 Cr | 34.45 Cr | 6.74 Cr | — |
| Available For Sale Securities | 80.47 Cr | 14.25 Cr | 34.11 Cr | 6.41 Cr | — |
| Goodwill And Other Intangible Assets | 0.23 Cr | 0.39 Cr | 0.19 Cr | 0.31 Cr | — |
| Other Intangible Assets | 0.23 Cr | 0.39 Cr | 0.19 Cr | 0.31 Cr | — |
| Net PPE | 54.71 Cr | 36.55 Cr | 22.71 Cr | 22.41 Cr | — |
| Gross PPE | 54.71 Cr | 58.34 Cr | 44.70 Cr | 43.07 Cr | — |
| Construction In Progress | 40.28 Cr | 28.17 Cr | 14.04 Cr | 12.90 Cr | — |
| Other Properties | 14.43 Cr | 9.97 Cr | 10.26 Cr | 11.09 Cr | — |
| Current Assets | 56.53 Cr | 109.73 Cr | 81.09 Cr | 75.90 Cr | — |
| Other Current Assets | 1.66 Cr | 1.43 Cr | 0.14 Cr | 60000.00 | — |
| Inventory | 8.88 Cr | 8.56 Cr | 8.34 Cr | 9.89 Cr | — |
| Other Receivables | 0.05 Cr | 4.93 Cr | 4.12 Cr | 2.10 Cr | — |
| Taxes Receivable | 0.16 Cr | 0.71 Cr | 0.27 Cr | 0.53 Cr | — |
| Accounts Receivable | 20.73 Cr | 19.48 Cr | 16.96 Cr | 15.21 Cr | — |
| Cash Cash Equivalents And Short Term Investments | 25.05 Cr | 73.97 Cr | 49.48 Cr | 46.59 Cr | — |
| Other Short Term Investments | 17.68 Cr | 69.84 Cr | 45.82 Cr | 41.55 Cr | — |
| Cash And Cash Equivalents | 7.36 Cr | 4.13 Cr | 3.66 Cr | 5.03 Cr | — |
| Retained Earnings | — | 134.12 Cr | 113.11 Cr | 108.53 Cr | 90.91 Cr |
| Additional Paid In Capital | — | 0.24 Cr | 0.24 Cr | 0.06 Cr | 0.06 Cr |
| Pensionand Other Post Retirement Benefit Plans Current | — | 0.93 Cr | 0.26 Cr | — | — |
| Other Payable | — | 4.63 Cr | 4.24 Cr | 4.85 Cr | 4.82 Cr |
| Dividends Payable | — | 0.66 Cr | 0.70 Cr | 0.70 Cr | 0.71 Cr |
| Non Current Prepaid Assets | — | 0.13 Cr | 0.53 Cr | 35.87 Cr | 22.95 Cr |
| Held To Maturity Securities | — | 0.32 Cr | 0.34 Cr | 0.33 Cr | 0.30 Cr |
| Financial Assets Designatedas Fair Value Through Profitor Loss Total | — | 0.32 Cr | 0.00 | — | — |
| Trading Securities | — | 2.84 Cr | 0.00 | — | — |
| Accumulated Depreciation | — | -21.80 Cr | -21.98 Cr | -20.66 Cr | -19.95 Cr |
| Machinery Furniture Equipment | — | 19.05 Cr | 17.77 Cr | 17.53 Cr | 16.25 Cr |
| Buildings And Improvements | — | 10.72 Cr | 12.48 Cr | 12.23 Cr | 11.77 Cr |
| Land And Improvements | — | 0.40 Cr | 0.40 Cr | 0.40 Cr | 0.40 Cr |
| Properties | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Restricted Cash | — | 0.66 Cr | 0.70 Cr | 0.70 Cr | 0.71 Cr |
| Prepaid Assets | — | 1.42 Cr | 1.09 Cr | 0.89 Cr | 1.07 Cr |
| Finished Goods | — | 5.67 Cr | 5.19 Cr | 6.09 Cr | 3.90 Cr |
| Work In Process | — | 0.08 Cr | 0.16 Cr | 0.60 Cr | 0.51 Cr |
| Raw Materials | — | 2.81 Cr | 2.98 Cr | 3.20 Cr | 3.17 Cr |
| Allowance For Doubtful Accounts Receivable | — | -2.24 Cr | -0.94 Cr | -0.28 Cr | -0.30 Cr |
| Gross Accounts Receivable | — | 21.71 Cr | 17.91 Cr | 15.48 Cr | 14.30 Cr |
| Cash Equivalents | — | 0.04 Cr | 0.14 Cr | 0.12 Cr | 1.27 Cr |
| Cash Financial | — | 4.09 Cr | 3.52 Cr | 4.91 Cr | 1.23 Cr |
| Treasury Shares Number | — | — | 0.02 Cr | — | — |
| Other Non Current Liabilities | — | — | -1000.00 | — | -1000.00 |
| Other Investments | — | — | 2.04 Cr | 1.22 Cr | — |
| Goodwill | — | — | 0.00 | 0.00 | 14000.00 |
| Net Debt | — | — | — | 0.78 Cr | 1.22 Cr |
| Other Inventories | — | — | — | -1000.00 | — |
| Other Equity Interest | — | — | — | — | 93.88 Cr |
| Current Deferred Taxes Liabilities | — | — | — | — | 0.20 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Jenburkt Pharmaceuticals Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.